Steve Pakola Sells $169K of Regenxbio Inc (RGNX) — SEC Form 4, May 13, 2026
Open-Market Net Sale · SEC Form 4
−$168,705
10b5-1 Plan
Equity position changed by -6.2%
Equity Position
233K sh
247,926 → 232,617
Equity Change
-6.2%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Steve Pakola CIK 0001700659 |
Officer
|
Steve Pakola at Regenxbio Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$939,970
More from this insider at Regenxbio Inc
| 2026-11-03 | Award | — | View |
| 2026-08-04 | - | — | View |
| 2026-07-06 | Sell | -$29,476 | View |
| 2026-07-02 | Sell | -$688,756 | View |
| 2026-03-12 | Sell | -$53,033 | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- This transaction was effected pursuant to a Rule 10b5-1 trading plan. Show more
- F2
- This transaction was executed in multiple trades at prices ranging from $11.00 to $11.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
Related filings at Regenxbio Inc
Institutional Holders
13F holders · Jun 30, 2026
166
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $76.6M
- Redmile Group, Llc $52.3M
- State Street Corporation $35.6M
5%+ Holders · 13D/G
4 filers
-
Jp Morgan Chase & Co 5.3%
-
Redmile Group, Llc 9.9%
-
Black Rock, Inc. 7.3%
Other insiders at Regenxbio Inc
GET /v1/forms/4/0001700659-26-000010
API docs
View Original SEC Filing